Emerging Trends in Cell Banking (Technical Insights)

Trends in Master and Working Cell Baking

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in drug discovery and development. On that note, cells and cell-based reagents constitute the foundations of most operational challenges. Indeed, cultured cells are frequently used to generate monoclonal antibodies (MAbs), enzymes, or substrates to be then utilized in other types of tests, such as ligand binding and enzymatic assays, thereby requiring distinct characterization and control measures to guarantee functional reliability over time.

The extreme sensitivity of cellular components to different chemical and physical elements and the possibility of alterations in the proteome expression profiles hold significant importance in assessing biopharmaceutical products. Therefore, the need for homogeneous, stable cell banks capable of safeguarding starting cellular material is substantial to perform reliable cell-based assays. Master and working cell banks (MCBs and WCBs) are established with the aim to provide a continuous source of viable cells that allow to generate accurate results for specific test methods.

This research service brings out the emerging trends in MCBs and WCBs on a global scale, through a detailed description of:
The technology capability and value chain; analysis of global technology trends.
An impact analysis of major drivers, restraints, and challenges influencing the growth of cell banks by timeframes.
An assessment of technology adoption and development, by region, demand side analysis, and recommendations for technology/product/services developers.
An evaluation of scenario modelling and emerging opportunities in MCBs and WCBs, technology management strategies and technology application roadmap.
A list of key patents of noteworthy innovations of global participants and a detailed list of key contacts in the field.

Table of Contents

Executive SummaryResearch ScopeResearch MethodologyKey FindingsTechnology Snapshot and TrendsTechnology Overview Technology Process Overview Technology Value ChainTechnology CapabilityTechnology CapabilityTechnology CapabilityTechnology CapabilityImpact Assessment and AnalysisMarket Impact of Key Innovations Market Impact of Key Innovations Market Impact of Technology Market Impact of Technology Diffusion of Innovations and Needs AssessmentTechnology Adoption Cycle Technology Adoption CycleTechnology Adoption Cycle Technology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleTechnology Adoption CycleOpportunity Evaluation and RoadmappingScenario Modelling and Emerging OpportunitiesDemand Side AnalysisDemand Side AnalysisBiophramas are increasing their partnerships with CMOs, for storing their proprietary cell lines and the development of novel cell lines.Company Profiles (continued)Company Profiles (continued)Company Profiles (continued)Company Profiles (continued)Company Profiles (continued)Key Contacts, Key Patents, andDecision Support DatabaseKey ContactsKey Contacts (continued)Key Contacts (continued)Key Contacts (continued)PatentsPatents (continued)DSD–Government Healthcare Expenditure (Billion USD)DSD–Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical MarketDSD–Pharmaceutical R&D Expenditure (Million USD)DSD–Total Healthcare Expenditure (Billion USD)DSD–Venture Capital Investment in Biotech R&D (Million USD)Legal DisclaimerThe Frost & Sullivan StoryWho is Frost & SullivanWhat Makes Us UniqueTEAM MethodologyOur Global Footprint 40+ Offices




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.